Edinburgh Cancer Research

Latest News

The following news articles were published in 2024.

Royal Society of Edinburgh grants awarded to IGC researchers

Erika Kague and Carlos Martinez-Perez
Research projects by Dr Erika Kague (Centre for Genomic and Experimental Medicine), and Dr Carlos Martinez-Perez and Dr Arran Turnbull, (Edinburgh Cancer Research), were awarded funding at the spring 2024 Research Awards open call.

Surgical resection outcome depends on ovarian cancer type

Impact of achieving complete macroscopic resection versus macroscopic residual disease in Scottish ovarian carcinoma cohort
A new paper shows the survival benefit associated with complete resection in ovarian cancer is histotype-specific: July 2024

New Science Director at Edinburgh Cancer Research

Professor Neil Carragher has been appointed as Director of Science at Edinburgh Cancer Research in the Institute of Genetics and Cancer: July 2024

Project pilots new rehabilitation model for adults with advanced cancer

The EU-funded INSPIRE project will guide future integrated palliative care and rehabilitation services for cancer: June 2024

Welcoming Professor Vincenzo D’Angiolella in the Institute of Genetics and Cancer

Vincenzo D’Angiolella, MD, PhD, Charles and Ethel Barr Chair of Cancer Research
Professor Vincenzo D’Angiolella, expert in protein degradation processes and brain cancer, joins the Institute of Genetics and Cancer as the Charles and Ethel Barr Chair of Cancer Research.

Adjuvant pembrolizumab improves survival in high-risk clear cell renal cell cancer

Pembrolizumab (Keytruda) prevents PD‑L1 and PD‑L2 ligand proteins on tumour cells from binding with PD⁠-⁠1 receptors on T cells
Recent results from the KEYNOTE-564 trial, an international study with its UK component led from Edinburgh, support adjuvant pembrolizumab as a standard of care after surgery for patients with clear cell renal cell cancer (kidney cancer): April 2024

Innovation and Entrepreneurship Award for University of Edinburgh and Nuvectis

Innovation and Entrepreneurship Awards 2024
University of Edinburgh and Nuvectis Pharma win Innovation and Entrepreneurship Award

£7.3m to provide next generation of cancer experts in Scotland

Logo of CRUK Clinical Academic Training Programme
Cancer Research UK awards funding to boost research: April 2024

Carragher Lab honours Emily’s memory

The family of a woman who died from a brain tumour aged just 31 have unveiled a plaque on the wall of the Neil Carragher Research Group lab, where the work they’ve helped to fund takes place: February 2024

Welcoming Dr Nezha Benabdallah to the Institute of Genetics and Cancer

Nezha Benabdallah
Dr Nezha Benabdallah, geneticist and cancer researcher, joins the Institute of Genetics and Cancer as a new principal investigator: February 2024

Autophagy linked to enhanced oncogenic signalling and brain tumour development

Graphical abstract of the study by Simpson et al.
A study shows that autophagy regulates oncogenic signalling of platelet-derived growth factor receptor alpha (PDGFRA) and that the absence of autophagy disrupts PDGFRA-driven brain tumour development: January 2024

First comprehensive molecular picture of ovarian carcinosarcoma

Genomic features of ovarian carcinosarcoma (OCS)
A study led by our scientists provides the first comprehensive molecular picture of ovarian carcinosarcoma (OCS), an uncommon form of ovarian cancer: January 2024

Shining a Light on Breast Cancer

Olga speaking at Shining a Light on Breast Cancer
During Breast Cancer Awareness Month we look back at our public Shining a Light event: October 2023

Local community welcomed for Doors Open Day

The Institute of Genetics and Cancer welcomed nearly 200 visitors for Doors Open Day: September 2023

Celebrating Technician Week at the University of Edinburgh

The essential work of technical staff has been highlighted through Technician Week events across the University in September